Introduction {#s01}
============

Stem cells must balance self-renewal and differentiation during development and tissue homeostasis. Understanding how different cell fates are established and maintained is critically important for both developmental biology and cancer research as disruption of this unique balance can result in tumorigenesis or tissue degeneration ([@bib53]). Generation of different cell fates after a stem cell division can be achieved either stochastically or through an asymmetric cell division ([@bib35]). When stem cells divide asymmetrically, one daughter cell reproducibly maintains stem cell identity while the other commits to differentiation ([@bib67]). Asymmetric cell division can be attained intrinsically whereby the stem cell segregates cell fate determinants into only one of the two daughter cells. Alternatively, the mitotic spindle of the stem cell is oriented so that after division only one of the two daughter cells continues to receive self-renewal factors released by the stem cell niche ([@bib39]). Ultimately, differential exposure to niche factors or unequal concentrations of segregating determinants need to be translated into distinct and stable cell fates by instructing or repressing particular transcriptional programs. These programs are implemented through very dynamic gene regulatory networks ([@bib28]). As most of our knowledge about transcriptional changes is based on end-point analysis, a time-resolved overview of these transitional states is essential to fully understand the molecular mechanisms shaping and maintaining the distinct fates of the two daughter cells. In this study, we fill this knowledge gap by establishing high-resolution time-course transcriptome datasets that extend our current understanding of the events occurring after stem cell division.

*Drosophila melanogaster* larval neuroblasts (NBs) are a well-established model system to study stem cell biology ([@bib20]; [@bib31]; [@bib34]). Several types of NBs can be distinguished in the central larval brain based on their division mode ([@bib6]; [@bib10]; [@bib13]). Type I NBs divide into a larger cell that retains NB characteristics and a smaller ganglion mother cell (GMC) that gives rise to two postmitotic neurons or glial cells (see [Fig. 1 a](#fig1){ref-type="fig"}). Type II NBs also divide asymmetrically, generating an NB and a smaller intermediate neural progenitor (INP) cell. Newly formed INPs go through defined maturation steps to become transit-amplifying INPs, which undergo three to six asymmetric divisions generating one INP and one GMC that also divides into two neurons or glial cells ([@bib6]; [@bib10]; [@bib13]).

NBs and INPs divide asymmetrically in an intrinsic manner through the differential localization of cell fate determinants. Brat, Numb, and Prospero (Pros) are segregated into the GMC to drive a differentiation program. Pros is a transcription factor that activates proneural genes and inhibits cell cycle genes ([@bib17]), whereas Brat acts as a translational repressor ([@bib70]) and Numb inhibits Notch signaling in the GMC by promoting endocytosis of the Notch receptor ([@bib65]; [@bib18]). Loss of these cell fate determinants disturbs the balance between differentiation and self-renewal. For example, in a *brat* mutant, type II NB--generated INPs fail to mature and revert into NB-like cells giving rise to transplantable tumors ([@bib15]; [@bib5]; [@bib8]; [@bib46]; [@bib13]).

Generation of different cell fates after asymmetric cell division implies several fundamental differences in the biology of the two daughter cells, including their proliferation and cell growth potential. Larval NBs regrow after each cell division to their original size before they continue dividing, whereas GMCs do not alter their cell volume ([@bib32]). NBs and GMCs also differ in their cell cycle times: type I NBs require 1.3 h for each cell division compared with 4.2 h for the final division of GMCs ([@bib13]; [@bib32]). The molecular machinery that regulates the asymmetric segregation of the cell fate determinants during mitosis is well understood. However, how the asymmetric distribution of the cell fate determinants translates into these fundamental differences between the two daughter cells is less clear ([@bib20]; [@bib63]; [@bib31]). A regulatory network including *deadpan*, *klumpfuss*, *worniu*, and *E(spl)mγ* that controls self-renewal in NBs has been identified ([@bib68]; [@bib55]; [@bib7]). Nevertheless, the dynamic molecular events stabilizing the distinct fates after asymmetric distribution of the cell fate determinants are poorly understood. To fill this gap, we performed time-resolved transcriptome analysis of NBs and maturing GMCs.

For this, we established a method to purify type I NBs and GMCs at three different time points after their asymmetric cell division. This is possible as cell cycle, cell growth, and maturation times in NBs are highly synchronous, allowing us to derive high-quality transcriptomes by pooling NBs and GMCs isolated at defined times after mitosis. We performed complex enrichment analysis using the Complex Enrichment Analysis Tool (COMPLEAT; [@bib76]) on the transcriptome data to determine protein complexes whose members undergo similar transcriptional changes in NBs and GMCs over time. This analysis highlighted a progressive down-regulation of the vacuolar-type H^+^--ATPase (v-ATPase) complex in GMCs over time. v-ATPase is a multisubunit proton pump found in the endomembrane system of all eukaryotic cells, where it is essential for the acidification of intracellular organelles, including endosomes and lysosomes. Consequently, v-ATPase plays a crucial role in protein trafficking and degradation and was only recently found to modulate several signaling transduction cascades ([@bib25]; [@bib73]; [@bib57]). We show that the v-ATPase complex is required for efficient NB self-renewal and acts in a regulatory loop involving the Notch signaling pathway. Our data indicate that this regulatory loop acts across multiple stem cell lineages at different times of the *Drosophila* life cycle. In addition, our data provide a resource for investigating neural developmental biology with high temporal resolution and may shed light on the mechanisms that establish the fundamental differences between stem cells and their differentiating sibling.

Results {#s02}
=======

Pure populations of larval NBs and GMCs of different ages can be obtained by FACS {#s03}
---------------------------------------------------------------------------------

To understand the temporal changes in NBs and GMCs, we retrieved transcriptomes from cells of different ages. To this end, we cultured FACS-sorted NBs from dissociated brains ([@bib7]; [@bib30]; [@bib32]) for 1.5, 3, or 5 h as they continued to divide asymmetrically ([Fig. 1 a](#fig1){ref-type="fig"}). To collect nearly pure populations of both NBs and GMCs, we subjected the cell suspension containing NBs and newly formed GMCs to a second FACS sort ([Fig. 1, a and b](#fig1){ref-type="fig"}; and Fig. S1). In each experiment, we obtained ∼1,000 NBs and, depending on the incubation time, up to 3,000 GMCs with a maximum age of 1.5, 3, or 5 h ([Fig. 1 c](#fig1){ref-type="fig"}). Low-input sequencing was achieved by combining transposon-mediated library preparation with molecular barcoding. Adding a unique identifier barcode to the 3′ end of each original cDNA molecule allowed us to extensively amplify our sequencing library without risking misrepresentation by PCR amplification artifacts ([@bib43]). In sum, the combination of our two-step FACS strategy and low-input sequencing technique allowed us to obtain the transcriptome of NBs and differently matured GMCs.

![**Pure populations of larval NBs and GMCs of different ages can be obtained by FACS. (a)** Larval central nervous systems (CNS) expressing a nuclear GFP in a type I NB--specific manner (*ase*-GAL4 and UAS-stingerGFP) were dissected and the tissue was disturbed into a single-cell solution. NBs were sorted according to cell size and GFP intensity (step 1) and were cultured in Schneider's medium for 1.5, 3, or 5 h (step 2); white arrowheads indicate NBs, and yellow arrowheads indicate GMCs. The mixture of NBs and newly formed GMCs was subjected to a second FACS sort, displaying two clearly distinct cell populations in the FACS plot. The population containing large cells with a high GFP intensity signal comprises NBs (Mira^+^), whereas the small cells with the low GFP signal intensity are GMCs. The FACS plot is a representative example of the second FACS sort after 3 h of NB culture (step 3). By using a GAL4 strain harboring both heterozygous and homozygous GAL4 and UAS-stingerGFP, we were able to separate two NB and two GMC populations when plotting the strength of the GFP signal to the size of the cells (forward scatter \[FSC\]-A). Both subpopulations are equal in size but different in the strength of the GFP signal as heterozygous insertions result in weaker GFP signals than homozygous insertions. **(b)** Essentially pure populations of NBs and GMCs were obtained after the second FACS sort. *n* (NB gate) = 849 cells, *n* (GMC gate) = 761 cells. **(c)** Increased incubation time between the two consecutive FACS sorts resulted in an increased GMC/NB ratio. *n* ≥ 3 Experiments. Error bars represent mean ± SD.](JCB_201711167_Fig1){#fig1}

To assess how the short culture period affected NB gene expression, we performed a differential expression analysis of our 1.5-, 3-, and 5-h NB datasets and identified 180 differentially expressed genes (false discovery rate \[FDR\] = 0.05, P \< 0.05; log2 fold change \[log2fc\] \>2; Fig. S2 a). However, the vast majority of these genes are lowly expressed (Fig. S2, b and c) and more than one third of them have an reads per million mapped reads (RPM) value of \<10 at all three time points (Fig. S2 b). Thus, only minor transcriptional changes affecting lowly expressed genes occur in NBs during the culture time, while most moderately or highly expressed genes remain unchanged. Hierarchical clustering of the log2RPM values of the 180 differently expressed genes showed that four out of five clusters were not enriched for any gene ontology (GO) term, indicating that NB culture does not affect a specific biological process within these clusters (Fig. S2 a). Cluster 4 contained predominantly genes that are lowly expressed in 1.5- and 3-h NBs but are up-regulated at the 5-h time point. Genes in this cluster were slightly enriched for the GO terms synaptic signaling and neuron development, indicating that longer culture might induce the expression of neuronal genes in NBs. Altogether, short-term NB culture has modest effects on the NB transcriptome. To avoid artifacts arising from those changes, however, we only compare NB and GMC datasets from identical culture times in the following analyses.

Time-resolved transcriptomics demonstrates gradual fate commitment {#s04}
------------------------------------------------------------------

2,438 genes were differentially expressed between NBs and GMCs isolated 1.5 h after asymmetric division (FDR = 0.05, P \< 0.05; log2fc \>1). Over time, the total number of genes expressed unequally between GMCs and NBs increased, reflecting their continuous move toward differentiation ([Fig. 2 a](#fig2){ref-type="fig"} and Table S1). 1,028 genes were deregulated between NBs and GMCs at all time points ([Fig. 2 b](#fig2){ref-type="fig"}), including the known NB markers *deadpan*, *worniu*, and *string* as well as the known differentiation/neuronal markers *dacapo*, *embryonic lethal abnormal vision*, and *nerfin-1*, confirming the reliability of our datasets (Fig. S2 e). Pros, Inscutable, Cherub, and Staufen RNAs are known to be asymmetrically inherited between NBs and GMCs ([@bib48]; [@bib37]; [@bib43]). Except for Staufen, all RNAs follow the expected trend, further verifying the high quality of our datasets (Fig. S2 d). Furthermore, we observed higher overlap of deregulated genes between the 1.5--3-h and 3--5-h time points compared with the 1.5--5-h time points, suggesting continuous and dynamic transcriptional changes over the lifetime of a GMC ([Fig. 2 b](#fig2){ref-type="fig"}).

![**Time-resolved transcriptomics demonstrates gradual fate commitment. (a)** The number of differentially expressed genes between NBs and GMCs increases over time. **(b)** Venn diagram representation of genes deregulated between NBs and GMCs at 1.5-, 3-, and 5-h time points and their respective overlap. **(c)** Unsupervised hierarchical clustering analysis of gene log2fc between NBs and GMCs at the indicated time point with subsequent GO term analysis of each cluster.](JCB_201711167_Fig2){#fig2}

We used unsupervised hierarchical clustering ([Fig. 2 c](#fig2){ref-type="fig"} and Table S2) to identify a set of genes whose expression in GMCs compared with NBs was increased throughout the time-course (clusters 1 and 5) and a set of genes expressed equally in NB and GMCs at the 1.5-h time point but up-regulated in GMCs at the later time points (clusters 6). As expected, genes in these clusters were enriched for the GO terms differentiation and neurogenesis. We also identified genes that were either permanently or progressively down-regulated in GMCs compared with NBs (clusters 2 and 3). These clusters were enriched for DNA replication and metabolic processes, consistent with the slower cell cycle and reduced proliferation capacity of GMCs. Other sets (clusters 4 and 7) contained genes expressed more highly in 1.5- and 3-h GMCs and less in 5-h GMCs compared with NBs. Surprisingly, these clusters scored for the GO terms synaptic signaling and learning and could include interesting candidates for further studies of neural differentiation processes. Taken together, the GMC fate program is not completely established immediately after asymmetric cell division but instead is a gradual process that occurs over the entire lifespan of the cell.

Complex enrichment analysis reveals the gradual transcriptional down-regulation of v-ATPase in GMCs {#s05}
---------------------------------------------------------------------------------------------------

To identify coregulated genes involved in similar molecular processes, we performed a protein complex enrichment analysis using COMPLEAT ([@bib76]). This revealed an increasing number of protein complexes differentially regulated between NBs and GMCs over time ([Fig. 3 a](#fig3){ref-type="fig"}). 137 complexes were down-regulated in GMCs compared with NBs at all three time points ([Fig. 3 b](#fig3){ref-type="fig"}). This included protein complexes required for DNA replication (e.g., Mcm2--7, GINS, and DNA polymerases), DNA repair (e.g., MSH2/6--BLM--p53--RAD51, PCNA--MutS--α--MutL--α--DNA complex, and BASC complex), regulation of the mitotic cell cycle progression and metabolic processes (e.g., β-oxidation, inosine monophosphate biosynthesis, and gluconeogenesis; [Fig. 3 c](#fig3){ref-type="fig"} and Table S3). Interestingly, only 36 complexes were up-regulated at all three time points in GMCs compared with NBs. The highest overlap of up-regulated complexes in GMCs versus NBs was detectable between 3 and 5 h, suggesting that GMCs first down-regulate complexes required for proliferation and subsequently up-regulate new sets of complexes promoting differentiation and their final division ([Fig. 3 b](#fig3){ref-type="fig"}). Complexes up-regulated in 3- and 5-h GMCs included the Notch corepressor complex spen--CtBP--Su(H) ([@bib58]), potentially reflecting an interesting cross talk between transcriptional regulation and post-transcriptional inhibition of Notch by Numb ([@bib65]; [@bib18]). In line with the emerging evidence for cell fate control by alternative splicing ([@bib16]; [@bib1]), we found several RNA splicing complexes (e.g., commitment complex and C complex spliceosome) up-regulated in GMCs compared with NBs. Finally, comparing mature GMCs and NBs revealed the up-regulation of several chromatin remodeling complexes (p300--CBP--p270--SWI/SNF and ING2 complex) and the Mediator--DRIP complex in GMCs, which have been shown to act as master coordinators of cell fate determination ([Fig. 3 d](#fig3){ref-type="fig"} and Table S3; [@bib23]; [@bib33]; [@bib80]). Altogether, we identified a core set of protein complexes deregulated between NBs and GMCs that might provide a framework for further analysis of cell fate establishment and maintenance.

![**Complex enrichment analysis reveals the gradual transcriptional down-regulation of v-ATPase in GMCs. (a)** The number of significantly differentially regulated complexes between NBs and GMCs increases over time. **(b)** Venn diagram representation of complexes that are down- or up-regulated in GMCs compared with NBs at a specific time point and their respective overlap. **(c)** Examples of protein complexes that were progressively down-regulated in GMCs compared with NB at all three time points (v-ATPase, left; Mcm2--7 complex, right). **(d)** Examples of protein complexes that were progressively up-regulated in GMCs compared with NBs (DRIP--Mediator complex, left; p300--CBP--p270--SWI/SNF complex, right). **(e)** Examples of protein complexes that were either down- (nuclear origin of replication recognition complex; v-ATPase) or up-regulated (Condensin; NURF complex) between young (1.5 h) and old (5 h) GMCs. **(f)** Endogenous Vha68-2-GFP protein expression. Vha68-2-GFP shows a strong signal in the cytoplasm and at the membrane of NBs, whereas a reduced signal was detectable in GMCs. Larval brains were stained for F-actin and Mira; arrowheads indicate NBs. **(g)** Quantification of Vha68-2-GFP protein expression levels in NBs and GMCs. *n* (NB) = 104, *n* (GMC) = 205 cells. Error bars represent mean ± SD. \*\*\*\*, P \< 0.0001; unpaired two-sided Student's *t* test. **(h)** Schematic of the v-ATPase complex (adapted from [@bib25]). A, Vha68-2; H, VhaSFD; a, Vha100-2; e, VhaM9.7-b; d, VhaAC39-1.](JCB_201711167_Fig3){#fig3}

To identify protein complexes that are deregulated in the process of GMC maturation, we compared the transcriptome of mature (5 h) and young (1.5 h) GMCs. The 343 protein complexes down-regulated in old compared with young GMCs included DNA replication complexes (Mcm2--7, nuclear origin of replication recognition complex, and DNA synthesome complex), the large and small ribosome subunits and complexes of the respiratory chain ([Fig. 3 e](#fig3){ref-type="fig"} and Table S3). This is expected as GMCs do not grow in cell size and slow down their cell cycle after asymmetric cell division. Complexes up-regulated during the maturation of GMCs included the Mediator--DRIP complex, chromatin remodeler (p300--CBP--p270--SWI/SNF complex and nucleosome remodeling factor \[NURF\] complex), the 13S condensin complex and genes related to the mitotic cell cycle G2/M transition DNA damage checkpoint ([Fig. 3 e](#fig3){ref-type="fig"} and Table S3). We propose that the increased expression of the 13S condensin complex and genes required for the G2/M transition relates to the final cell division of the GMC into two neurons/glia cells. Additionally, the NURF complex was shown to be essential for the differentiation of melanocyte stem cells ([@bib42]), suggesting the intriguing possibility that NURF could play a similar role in GMC differentiation.

Among the protein complexes we identified, the v-ATPase complex stood out as it is one of the few complexes gradually down-regulated in GMCs over time, both when compared with NBs as well as when compared with each other ([Fig. 3, c, e, and h](#fig3){ref-type="fig"}; and Fig. S3, a and b). Asymmetric inheritance of RNAs between NBs and GMCs has been reported previously ([@bib48]; [@bib37]; [@bib43]). Therefore, we performed FISH for the catalytic v-ATPase subunit Vha68-2. During NB division, no asymmetric mRNA localization was detectable, suggesting that Vha68-2 mRNA is not asymmetrically segregated between NBs and GMCs and that different mechanisms are responsible for v-ATPase down-regulation in GMCs (Fig. S3, c and d). To confirm the transcriptome data, we generated a fly strain where *Vha68-2* was tagged with GFP. *Vha68-2-*GFP was strongly expressed in a punctate manner in the cytoplasm and at the cell membrane of NBs, whereas a significantly reduced Vha68-2-GFP signal was detectable in GMCs ([Fig. 3, f and g](#fig3){ref-type="fig"}). Thus, consistent with the transcriptome data, the v-ATPase complex is down-regulated in GMCs after asymmetric cell division.

v-ATPase is required for NB regrowth after asymmetric cell division {#s06}
-------------------------------------------------------------------

To understand the function of v-ATPase, we inhibited its components by RNAi in type I NBs. Both depletion of the catalytic subunit ([Fig. 4, a and b](#fig4){ref-type="fig"}) and inhibition of several other v-ATPase subunits ([Fig. 4 b](#fig4){ref-type="fig"}) resulted in a prominent reduction in NB size, suggesting that v-ATPase might be required for cell growth. To further understand this loss of function phenotype, we performed ex vivo live imaging of NBs labeled by nuclear GFP ([@bib32]). It is well established that larval NBs regrow after each cell division to their original size before they continue dividing, while GMCs do not alter their cell volume ([@bib32]). In line with that ex vivo control NBs regrew to their original size after each cell division ([Fig. 4, c and d](#fig4){ref-type="fig"}; and Video 1). v-ATPase deficient NBs still divided into two daughter cells of unequal size but did not grow to the same extent as control NBs before the next division ([Fig. 4, c and d](#fig4){ref-type="fig"}; and Videos 2 and 3). GMCs generated by control or v-ATPase deficient NBs, instead did not show volume alterations during their lifespan ([Fig. 4 e](#fig4){ref-type="fig"}). In addition, cell cycle time in NBs but not in GMCs was prolonged upon v-ATPase knockdown ([Fig. 4 f](#fig4){ref-type="fig"}). Thus, v-ATPase is required for cell growth in NBs but not in GMCs, consistent with its down-regulation in GMCs. We also observed a significant decrease in NB number upon v-ATPase knockdown ([Fig. 4, g and h](#fig4){ref-type="fig"}). To exclude apoptosis as a potential explanation for the loss of v-ATPase^RNAi^ NBs, we performed TdT dUTP Nick-End labeling (TUNEL) assays and did not observe any TUNEL-positive NBs upon v-ATPase depletion (Fig. S3 e). This confirms previous research showing that NBs, like other stem cells, can only maintain their stemness if they grow at a minimum rate ([@bib69]). Thus, v-ATPase promotes NB self-renewal by driving cell cycle progression and NB regrowth after asymmetric cell division.

![**The v-ATPase is required for NB regrowth after asymmetric cell division. (a)** *Vha68-2* inhibition by RNAi caused a reduction in NB size. Images are magnifications of the red boxes in g. Larval brains were stained for the stem cell marker Mira. **(b)** Quantification of NB diameter upon knockdown of *Vha68-2*, *Vha100-2*, or *VhaAC39-1*. Each data point represents the average type I NB diameter per brain lobe. *n* (control) = 14, n(*Vha68-2*^RNAi^) = 10, *n* (*Vha100-2*^RNAi^) = 10, *n* (*VhaAC39-1*^RNAi^) = 11. **(c)** *Vha100-2* knockdown by RNAi resulted in a defect in NB regrowth after asymmetric cell division and in a prolonged NB cell cycle time. GMC cell cycle times were not altered. Single frames from time-lapse videos of cultured NBs expressing UAS-stingerGFP under the control of *ase*-GAL4. Asterisks label NBs. Time in hours:minutes. **(d)** Automated quantification of volume variation with each cell division of control or *Vha100-2*^RNAi^ NBs. *n* (control) = 5, *n* (*Vha100-2*^RNAi^) = 5. Div, cell division. **(e)** Automated quantification of volume variation within the lifespan of GMCs originating either from control or from *Vha100-2*^RNAi^ NBs. *n* (control) = 5, *n* (*Vha100-2*^RNAi^) = 5. **(f)** Quantification of cell cycle times of control or *Vha100-2*^RNAi^ NBs and their siblings. Each data point represents the duration of one cell cycle. *n* (NB control) = 19, *n* (NB *Vha100-2*^RNAi^) = 23, *n* (GMC control) = 8, *n* (GMC *Vha100-2*^RNAi^) = 12. **(g)** *Vha68-2* depletion by RNAi caused a reduction in NB number. Larval brains were stained for Mira. CB, central brain. **(h)** Quantification of NB number per brain lobe upon knockdown of *Vha68-2*, *Vha100-2*, or *VhaAC39-1*. Each data point represents the number of type I NBs per brain lobe. *n* (control) = 8, *n* (*Vha68-2*^RNAi^) = 8, *n* (*Vha100-2*^RNAi^) = 10, *n* (*VhaAC39-1*^RNAi^) = 6. Error bars represent mean ± SD. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001; unpaired two-sided Student's *t* test.](JCB_201711167_Fig4){#fig4}

v-ATPase is required for Notch signaling in NBs {#s07}
-----------------------------------------------

The interplay between v-ATPase and several signaling pathways including TOR, Wnt, Notch, and JNK signaling has been reported previously ([@bib79]; [@bib14]; [@bib19]; [@bib75]; [@bib85]; [@bib60]; [@bib27]). Because our transcriptome datasets showed down-regulation of Notch target gene expression in GMCs compared with NBs (Table S1) and because Notch signaling is essential for NB self-renewal ([@bib64]; [@bib69]), we investigated a potential interaction between v-ATPase and the Notch signaling pathway. Loss of v-ATPase resulted in reduced expression levels of the Notch reporter E(spl)mγ-GFP ([@bib3]), suggesting that v-ATPase is required for an active Notch signaling pathway in NBs ([Fig. 5, a and b](#fig5){ref-type="fig"}). Indeed, the mRNA levels for E(spl)mγas well as other Notch targets were down-regulated in FACS-purified *Vha68-2*^RNAi^ NBs ([Fig. 5 c](#fig5){ref-type="fig"}). Furthermore, depletion of Notch by RNAi caused reduced NB diameter, phenocopying the effect of v-ATPase inhibition by RNAi ([Fig. 5, d and e](#fig5){ref-type="fig"}). Therefore, v-ATPase is required for an active Notch signaling pathway in NBs.

![**Regulatory loop between Notch signaling and v-ATPase orchestrates NB growth and self-renewal. (a)** Depletion of *Vha68-2* by RNAi resulted in reduced protein expression of the Notch reporter E(spl)mγ-GFP. Larval brains were stained for Mira. **(b)** Quantification of E(spl)mγ-GFP signal intensity in control and *Vha68-2*^RNAi^ NBs. *n* (control) =3, *n* (*Vha68-2*^RNAi^) = 3 brain lobes. **(c)** Expression levels of Notch target genes in sorted NBs assessed by quantitative RT-PCR upon depletion of *Vha68-2* by RNAi. *n* = 3 experiments. **(d)** Knockdown of *Notch* in NBs resulted in decreased NB size. Larval brains were stained for Notch^Intra^ and Mira. **(e)** Quantification of NB diameter upon *Notch* depletion by RNAi. Each data point represents the mean type I NB diameter per brain lobe. *n* (control) = 13, *n* (*Notch*^RNAi^) = 10. **(f)** Down-regulation of *Vha68-2-GFP* protein expression upon *Notch*^RNAi^. Larval brains were stained for F-actin and Mira. Arrowheads indicate NBs. **(g)** Quantification of Vha68-2-GFP signal intensity in control and *Notch*^RNAi^ NBs. *n* (control) = 14, *n* (*Notch*^RNAi^) = 14 brain lobes. **(h)** Expression levels of v-ATPase subunits in FACS-purified NBs assessed by quantitative RT-PCR upon *Notch* depletion by RNAi. *n* = 4 experiments. Error bars represent mean ± SD. \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001; unpaired two-sided Student's *t* test.](JCB_201711167_Fig5){#fig5}

v-ATPase and the Notch signaling pathway form a regulatory loop {#s08}
---------------------------------------------------------------

Because Notch signaling is active in NBs but not in GMCs, we next asked whether v-ATPase expression in NBs might be driven through a regulatory loop involving the Notch signaling pathway. Interestingly, Vha68-2--GFP protein expression levels were significantly reduced upon *Notch* depletion ([Fig. 5, f and g](#fig5){ref-type="fig"}). Furthermore, sorted Notch-deficient NBs showed transcriptional down-regulation of all probed v-ATPase subunits, suggesting that the Notch singling pathway is either directly or indirectly driving v-ATPase expression in NBs ([Fig. 5 h](#fig5){ref-type="fig"}). Altogether, our results suggest that a regulatory loop between the Notch signaling pathway and v-ATPase ensures NB self-renewal.

v-ATPase is required for *brat* tumor progression {#s09}
-------------------------------------------------

As the Notch pathway is one of the most common signaling pathways in cancer ([@bib81]) and v-ATPase is considered a potential anticancer target ([@bib72]), we tested the significance of the connection between v-ATPase and the Notch signaling pathway for tumor development. It is well established that mutations affecting asymmetric NB division (e.g., *brat* mutations) can result in persistent proliferation of both daughter cells and the formation of lethal, transplantable brain tumors ([@bib15]; [@bib5]; [@bib8]; [@bib13]; [@bib34]). To test whether deregulation of the Notch/v-ATPase regulatory loop might be implicated in the formation of those tumors, we inhibited both Notch and v-ATPase using RNAi. As has been shown for *Notch^RNAi^* ([@bib69]), *v-ATPase^RNAi^* significantly reduced the brain tumor volume in larvae ([Fig. 6, a and b](#fig6){ref-type="fig"}). Like Notch signaling, v-ATPase is required for *brat* tumor progression in adult flies as it delays the increase of an RFP signal driven by a tumor NB-specific promoter ([Fig. 6 c](#fig6){ref-type="fig"}). Consistently, the lifespan of *brat*^RNAi^ tumor bearing flies is significantly increased upon simultaneous Notch or v-ATPase inhibition ([Fig. 6 d](#fig6){ref-type="fig"}). We also tested whether pharmacological inhibition of v-ATPase could rescue tumor progression. For this, we transplanted 1,000 *brat* tumor cells each into WT host flies and then injected the v-ATPase inhibitor bafilomycin A1 (Baf-A1; [Fig. 6 e](#fig6){ref-type="fig"}). Flies treated with a single dose of Baf-A1 showed delayed tumor progression ([Fig. 6, f and g](#fig6){ref-type="fig"}), resulting in a significant delay in metastasis-induced lethality ([Fig. 6 h](#fig6){ref-type="fig"}). These results indicate that v-ATPase is required for Notch-dependent *brat* tumor progression.

![**v-ATPase is required for *brat* tumor progression. (a)** Knockdown of either the *v-ATPase* or *Notch* in a *brat*^RNAi^ background results in reduced larval brain tumor volume compared with mCherry^RNAi^ control. Larval brains were stained for Mira. OL, optic lobe. **(b)** Quantification of the brain tumor volume upon knockdown of *brat* in the combination with mCherry^RNAi^, *Vha68-2*^RNAi^, *Vha100-2*^RNAi^, or *Notch*^RNAi^. Each data point represents the volume of one brain lobe. *n* (mCherry^RNAi^) = 9, *n* (*Vha68-2*^RNAi^) = 11, *n* (*Vha100-2*^RNAi^) = 6, *n* (*Notch*^RNAi^) = 8. Error bars represent mean ± SD. \*\*\*\*, P \< 0.0001; unpaired two-sided Student's *t* test. **(c)** *Vha68-2*^RNAi^ or *Notch*^RNAi^ slowed down brat tumor progression and increased the survival of adult flies compared with *brat*^RNAi^, *mCherry*^RNAi^ control. *mCherry*^RNAi^ does not target the RFP that we used to label tumor cells. Pictures of real-time tumor metastasis burden; RFP signal is displayed in false colors (BRGBCMYW). **(d)** Kaplan--Meier plot showing the increased survival of adult flies upon *Vha68-2*^RNAi^ or *Notch*^RNAi^ compared with mCherry^RNAi^ in a *brat*^RNAi^ background. *n* = 10 flies per genotype. **(e)** Cartoon depicting transplantation of *brat* tumors into adult host flies and subsequent treatment of these flies. CNS, central nervous system. **(f)** Single injection of Baf-A1 slows down *brat* tumor progression and prolongs fly survival compared with vehicle control. Pictures of real-time tumor metastasis burden; RFP signal is displayed in false colors (BRGBCMYW). First detectable metastasis appeared 3 d later in Baf-A1--treated flies in comparison with nontreated flies. **(g)** RFP signal intensity quantification of whole flies; RFP signals of all flies on one picture were averaged. *n* = 3 experiments. **(h)** Kaplan--Meier plot showing the increased survival of Baf-A1--treated flies compared with vehicle-treated flies. *n* ≥ 9 flies per genotype. \*, P \< 0.05; \*\*, P \< 0.01; Mantel--Cox test.](JCB_201711167_Fig6){#fig6}

To directly test the significance of the regulatory loop between v-ATPase and the Notch signaling pathway for tumor development, we expressed a constitutively active Notch in NBs, which resulted in brain tumor formation as previously reported ([@bib77]; [@bib13]). Additional loss of v-ATPase resulted in significantly reduced brain tumor volume (Fig. S4, a and b), suggesting that v-ATPase is required for Notch-driven tumor progression.

v-ATPase depletion induces overproliferation of intestinal stem cells (ISCs) {#s10}
----------------------------------------------------------------------------

v-ATPase could be required for *brat* tumor progression either because of its basic cell-essential housekeeping function ([@bib2]; [@bib9]) in protein trafficking and degradation or more specifically because of its role in Notch signaling. To distinguish those possibilities, we investigated the role of v-ATPase in *Drosophila* ISCs. ISCs maintain the adult *Drosophila* midgut by repeated asymmetric cell divisions ([@bib54]). ISCs self-renew and give rise to enteroblasts (EBs) that differentiate into either polyploid enterocytes (ECs) or enteroendocrine cells ([Fig. 7 a](#fig7){ref-type="fig"}). Unlike in NBs, where *Notch^RNAi^* causes underproliferation, loss of Notch in ISC lineages of the posterior midgut (*Notch^RNAi^* driven by *esg-*GAL4) results in the overproliferation of ISC/EB-like cells ([@bib56]). Interestingly, depletion of v-ATPase in ISCs and EBs caused overproliferation rather than loss of esg^+^ ISC/EB-like cells at the expense of ECs in the posterior midgut ([Fig. 7, b and c](#fig7){ref-type="fig"}). Loss of either v-ATPase or Notch resulted in significantly reduced expression levels of the Notch reporter NRE-LacZ ([Fig. 7, d and e](#fig7){ref-type="fig"}; [@bib26]; [@bib51]). Thus, v-ATPase promotes Notch signaling in stem cell lineages, resulting in distinct consequences for intestinal and neural stem cells. Furthermore, sorted Notch-deficient esg^+^ ISC/EB-like cells showed transcriptional down-regulation of probed v-ATPase subunits, indicating that the Notch signaling pathway drives v-ATPase expression in ISCs ([Fig. 7 f](#fig7){ref-type="fig"}).

![***v-ATPase*^RNAi^ induces ISC/EB overproliferation. (a)** *Drosophila* ISCs divide asymmetrically to self-renew and generate EBs. EBs differentiate to either ECs or enteroendocrine cells (EECs). *Esg* is expressed in ISCs and EBs; the Notch reporter NRE marks EBs. **(b)** Depletion of either *Vha100-2* or *Notch* in ISCs by *esg*-GAL4 induced overproliferation of esg^+^ ISC/EB-like cells in the expanse of ECs in the posterior midgut (arrowheads). v-ATPase seems to promote Notch signaling in stem cell lineages, resulting in distinct consequences for ISCs and neural stem cells. Green represents *esg*-GAL4, UAS-GFP visualized by anti-GFP staining. **(c)** Percentage of esg^+^ ISC/EB-like cells per posterior midgut image. *n* (mCherry^RNAi^) = 9, *n* (*Vha100-2*^RNAi^)=12, *n* (*Notch*^RNAi^) = 8. **(d)** Depletion of either *Vha100-2* or *Notch* by *esg*-GAL4 results in reduced expression levels of the Notch reporter NRE-LacZ. NRE^+^ cells are marked by arrowheads. Green represents *esg*-GAL4, UAS-GFP visualized by anti-GFP staining. **(e)** Quantification of the percentage of NRE^+^ cells among esg^+^ cells per midgut image. *n* (mCherry^RNAi^) = 9, *n* (*Vha100-2*^RNAi^) = 9, *n* (*Notch*^RNAi^) = 9. **(f)** Expression levels of v-ATPase subunits in sorted esg^+^ ISC/EB-like cells assessed by qRT-PCR upon depletion of *Notch*. *n* = 3 experiments. Error bars represent mean ± SD. \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001; unpaired two-sided Student's *t* test.](JCB_201711167_Fig7){#fig7}

Taken together, our data indicate that the interplay between v-ATPase and the Notch signaling pathway accounts for reduced *brat* tumor progression upon v-ATPase knockdown. Furthermore, we demonstrated that the regulatory loop between v-ATPase and Notch is not exclusive to the brain but acts in other stem cells as well.

Discussion {#s11}
==========

Our results establish a method for quantifying the transcriptional changes occurring in the two daughter cells of an asymmetric stem cell division over time. We purified NBs and GMCs at different time points during their development, which enabled us to follow transcriptional changes that occur during the process of differentiation upon asymmetric cell division with high temporal resolution.

Previous studies have successfully described transcriptome dynamics during differentiation in several mammalian stem cell systems, including neural, cardiac, and pancreatic tissue ([@bib78]; [@bib24]; [@bib61]; [@bib36]). These studies followed the differentiation of stem cells into specified cell types over days or weeks, which allowed the identification of optimal cell culture conditions for differentiation or to determine sets of genes or pathways required for the fate commitment of specific cell types. Our study complements these experiments by providing a highly time-resolved transcriptome analysis that assesses the fast changes occurring in differentiating daughter cells after asymmetric cell division. The combination of our time-resolved transcriptomes and the protein complex enrichment analysis lays the foundation for a more targeted search for factors and protein complexes that are required to stabilize the NB or GMC fate. Multiple protein complexes known for their role in fate regulation in several distinct species were enriched in our dataset, providing the potential applicability of this knowledge to other stem cell systems.

We identified the v-ATPase complex as one of the strongest and most consistently differently expressed complexes between NBs and GMCs over time. Our study reveals a regulatory loop between v-ATPase and the Notch signaling pathway in NBs. This interplay ensures the balance between self-renewal and differentiation and therefore constitutes an additional and novel layer of Notch signal pathway regulation in NB lineage development. The requirement for Notch signaling during G1/S transition in neural stem cells ([@bib11]) could explain the prolonged NB cell cycle time observed upon v-ATPase knockdown. v-ATPase expression by the Notch signaling pathway is further supported by transcriptome data showing that the expression of all v-ATPase subunits are more highly expressed in the Notch-active ECs compared with ISCs ([@bib22]). Our experiments in the adult ISC system are also conceptually surprising: reducing the expression of a protein complex that was initially considered as a "housekeeping" complex was able to induce an overproliferation of stem-like cells. This highlights the role of the v-ATPase in cellular signaling and tissue homeostasis.

Previous studies suggested that v-ATPase acts in endosomes to create an acidic environment required for efficient Notch S3 cleavage ([@bib79]; [@bib75]; [@bib44]). The S3 cleavage process generates the free Notch intracellular domain that translocates to the nucleus to drive target gene expression ([@bib65]). Although it is likely that the v-ATPase plays a similar role during Notch signaling in NBs, it is less clear what drives v-ATPase expression in NBs but not in GMCs. In other tissues, either Rbcn-3 or the transcription factor Mitf can induce the expression of v-ATPase subunits ([@bib79]; [@bib83]; [@bib12]; [@bib74]). In *Drosophila* NBs, however, neither loss nor overexpression of Mitf nor loss of Rbcn-3 had any effect on self-renewal capacity (unpublished data). Our results indicate that the Notch pathway is driving v-ATPase expression in NBs. This effect seems to be indirect, as v-ATPase is not among the targets suggested by chromatin immunoprecipitation analysis of the Notch-binding protein Su(H) in hyperplastic *Drosophila* larval brains ([@bib82]). Consistently, prominent Notch targets such as E(spl) act as transcriptional repressors ([@bib59]) that could indirectly influence v-ATPase in NBs and GMCs.

Interestingly, reduced v-ATPase expression in NBs caused them to acquire GMC-specific characteristics including a prolonged cell cycle time and a reduced proliferation and cell growth potential. This raises the exciting possibility that overexpression of the v-ATPase complex might revert GMCs into NB-like cells as does overexpression of E(spl)mγ ([@bib7]). As the v-ATPase complex contains 15 core subunits (many of which are gradually down-regulated), such a gain-of-function study would be technically very challenging. We nonetheless generated transgenic *Drosophila* lines driving the overexpression of the three most strongly down-regulated v-ATPase subunits. However, even upon simultaneous overexpression of those three transgenes in both type I and type II NBs and GMCs, self-renewal and differentiation behavior was not detectably changed (unpublished data). This result could be explained by an uneven stoichiometry of all the functional v-ATPase complex subunits. Alternatively, additional factors not present in GMCs could be required for v-ATPase to be active; v-ATPase activity was shown to be regulated by a reversible assembling processes of the two major domains V~0~ and V~1~ depending on nutrients response, cell maturation, hormones, and growth factors ([@bib57]).

The Notch pathway is one of the most commonly activated signaling pathways in cancer ([@bib81]). Our data show that inhibition of the v-ATPase either genetically or chemically impairs proliferation capacity of the Notch signaling-dependent *brat* tumors. Consistently, cell proliferation can be reduced in Notch-addicted breast tumor cell lines upon v-ATPase inhibition ([@bib40]). Based on this and other research, v-ATPase is considered as a potential novel anticancer target ([@bib72]). We demonstrated that reduction of v-ATPase expression in ISCs and EBs primarily affects Notch signaling, suggesting that the regulatory loop involving v-ATPase and the Notch pathway might also be critical for *brat* tumor progression. Investigating whether a similar pathway operates in human tumors as well might result in important mechanistic insight into the mechanism of action for v-ATPase inhibiting antitumor compounds.

In conclusion, we provide a time-resolved transcriptome dataset that represents a significant resource for investigating new mechanisms of neural stem cell biology and might help to explain how the fundamental differences between stem cells and their differentiating siblings are established.

Materials and methods {#s12}
=====================

Fly strains and RNAi analysis {#s13}
-----------------------------

The following *Drosophila* stocks were used: UAS-*Vha68-2*^RNAi^ (34390; Vienna Drosophila Resource Center \[VDRC\] and BL34582; Bloomington Drosophila Stock Center), UAS-*Vha100-2*^RNAi^ (30297; VDRC), UAS-*VhaAC39-1*^RNAi^ (20950; VDRC), *E(spl)mγ*-GFP ([@bib3]), *NRE*-LacZ; *esg*-GAL4, UAS-GFP*, tubulin*-GAL80^ts^ ([@bib51]), UAS-*Notch*^RNAi^ (100002; VDRC), UAS-NotchΔECD ([@bib45]), UAS-*brat*^RNAi^ (31333; VDRC), and UAS-mCherry^RNAi^ (BL35785). The following GAL4 driver lines were used: UAS-*dcr2*; *ase*-GAL4, UAS-stingerGFP ([@bib4]), *ase*-GAL4 ([@bib84]), UAS-*dcr2*; *wor*-GAL4, *ase*-GAL80 ([@bib55]), UAS-stingerRFP ([@bib33]), and *esg-*GAL4, UAS-mCD8::GFP, *tubulin*-GAL80^ts^ ([@bib29]).

Stock generated in this study was Vha68-2-GFP. gRNA was cloned into pU6-BbsI-chiRNA (45946; 100 ng/μl; Addgene) and coinjected with the donor plasmid (250 ng/μl) into act\>Cas9 embryos. The gRNA used was GGAGGACTAGAGACCGCGC.

Fly crosses were set up at 25°C for 24 h and then shifted to 29°C. For experiments in [Fig. 7 (b--f)](#fig7){ref-type="fig"}, fly crosses were set up and reared at 18°C. 3-d-old female flies were shifted to 29°C for 6 d. For the *brat* rescue, double RNAi crosses were set up and reared at 29°C. Flies were collected 2 d after eclosion and kept at 29°C.

Antibodies and immunohistochemistry {#s14}
-----------------------------------

Larval brains were dissected in PBS and fixed at RT in 5% PFA in PBS for 20 min. Brains were washed three times with 0.1% Triton X-100 in PBS (PBST) and incubated 1 h in blocking solution (1% normal goat serum in PBST). Incubation with primary antibodies in blocking solution was performed overnight at 4°C. Brains were washed three times with PBST, incubated for 2 h at RT with secondary antibody, washed five times with PBST, and mounted in Vectashield mounting medium (containing DAPI; Vector Labs).

Dissected guts were fixed in PBS containing 4% PFA for 30 min at RT. Guts were washed with PBS and blocked in PBS containing 0.05% of Tween-20 and 5% of normal goat serum (blocking solution) for 1 h. Guts were then incubated with primary antibodies (contained in blocking solution) overnight at 4°C. Guts were then washed three times for 15 min in PBS containing 0.05% of Tween-20 (washing solution) and labeled with secondary antibodies (contained in blocking solution) overnight at 4°C. Finally, guts were washed three times for 15 min in washing solution and mounted in a solution of Vectashield/DAPI (Vector Labs).

Antibodies used in this study were rabbit anti-Mira (1:250; [@bib8]), guinea pig anti-Mira (1:200; [@bib23]), chicken anti-GFP (1:500; ab13970; Abcam), mouse anti-Notch^intra^ (1:1,000; C17.9C6; Developmental Studies Hybridoma Bank), mouse anti--β-galactosidase (1:100; Z378B; Promega), mouse anti-Dacapo (1:100; AB_10805540; Developmental Studies Hybridoma Bank), rat anti-Elav (1:100; 7E8A10; Developmental Studies Hybridoma Bank), guinea pig anti-Dpn (1:1,000; [@bib23]), mouse anti-Pros (1:100; Developmental Studies Hybridoma Bank), and Alexa Fluor 568 phalloidin (A12380; Invitrogen).

Secondary antibodies were coupled to Alexa Fluor 405, Alexa Fluor 488, Alexa Fluor 568, and Alexa Fluor 647 (Invitrogen; all used in 1:500 dilution). An in situ cell death detection kit (TMR red; 12156792910; Roche) was used for the TUNEL assay.

Microscopy and in vitro live imaging {#s15}
------------------------------------

Immunofluorescence images were acquired at room temperature using ZEN 2011 software (Zeiss) on an LSM780 microscope (Zeiss) equipped with a GaAsP detector and 25×/0.8 Plan Apochromat or 40×/1.4 enhanced chemiluminescence Plan Apochromat oil differential interference contrast or 40×/1.3 enhanced chemiluminescence Plan-Neofluar oil differential interference contrast objectives (Zeiss).

In vitro live imaging of cultured cells was performed using an UltraView Vox spinning-disk confocal system (PerkinElmer) installed on an AxioObserver Z1 microscope (Zeiss). Images were recorded with an Hamamatsu electron-multiplying charge-coupled device 9100-13 camera using 40×/1.3 enhanced chemiluminescence Plan Neofluar lens (Zeiss). Acquisition of video sequences was done with the Volocity 3D image software (PerkinElmer). Multiple positions were acquired simultaneously. At each position, z stacks were captured every 3 min. Collected images were deconvolved using Huygens deconvolution suite (SVI). Nuclei volumes and cell cycle times were automatically analyzed using Definiens as described previously ([@bib32], [@bib33]).

FISH {#s16}
----

FISH was performed as previously described ([@bib43]) with minor changes. Briefly, L3 brains were fixed at RT for 40 min in 5% PFA. Brains were washed three times with PBST and then permeabilized in 70% ethanol overnight at 4°C. Ethanol was removed, and brains were incubated at 37°C for 5 min in 400 µl washing buffer (2× SSC and 10% formamide). Upon removal of the washing buffer, brains were incubated in the dark in 100 µl hybridization buffer (1 mg/ml *Escherichia coli* tRNA, 2 mM vanadyl ribonucleoside complex, 200 nM BSA, 2× SSC, 10% formamide, and 100 mg/ml dextran sulfate) including the FISH probes at 37°C for 6 h. Brains were washed twice with washing buffer, each time for 30 min at 30°C and mounted in 2× SSC. Vha68-2 FISH probes were labeled with Quasar 570 dye and designed using the Stellaris probe designer (Stellaris Biosearch Technologies).

Against Vha68-2 mRNA (labeled with Quasar 570 dye), we used 5′-CCAACTCGTACATAGCTGAT-3′, 5′-ACCGGATCTCCGACAGTTAC-3′, 5′-GAAAGAGGCTTGCCGGTACG-3′, 5′-AAAGATGCTGCCCATGATAC-3′, 5′-AGCTCGTTAATGTCCTTCAG-3′, 5′-TGGGGATGTAGATGGATTCG-3′, 5′-GACAAACTGGGCACGTTCAC-3′, 5′-TTGACGTTCAGGGGGTTGAA-3′, 5′-TTGACCAGAGTGTTCTCATG-3′, 5′-GGGGTTCACAATCATCTTGT-3′, 5′-TGATCTCTCCATCGAACTCG-3′, 5′-CACACCTGCAACATGGTGTG-3′, 5′-GAAGAGCGAGTCGAGCACAC-3′, 5′-AACCGAAAGCTCCGGGAATG-3′, 5′-CTGCGAGATCACAGTCTTGC-3′, 5′-ATCGGAGTTGGAGTACTTGG-3′, 5′-CGCAACCGACGTAGATGATG-3′, 5′-TACCTCAGACATCTCGTTAC-3′, 5′-TTCATGATGGACTCGGTGAC-3′, 5′-CAGGCATGTTGGAGGTGTTG-3′, 5′-GATACCAGTGTAGATGGAGG-3′, 5′-ATCACGGAAGTATTCGGACA-3′, 5′-TCATGGACACGTTGTAACCC-3′, 5′-CAACGGGAGGTGGAATCAGC-3′, 5′-AATTTCACGAAGAGCCTCAG-3′, 5′-AGGCATCTCAGCGAGACGAC-3′, 5′-TCGTAGAAGGAGGCCAGACG-3′, 5′-GGTTACCCAAGCACTTAACG-3′, 5′-GAGACACAGCTCCGACAATG-3′, 5′-CACGGGATCGGAGAAGTCAC-3′, 5′-CAGAACACCTGCACGATACC-3′, 5′-GGCCAACTTCTTGTCGAGAC-3′, 5′-CAGTTGATCGAGGGGAAGTG-3′, 5′-GCATGTACTTCGAGTAGGAG-3′, 5′-TCATAGAAGTCATCCAGAGC-3′, 5′-CACGAATTCGGGGAAGTTCT-3′, 5′-GATCTCCTTGACCTTGGTAC-3′, 5′-TGCACGATCTCAGACAGATC-3′, 5′-AGCGTGATCTTGTCGGTTTC-3′, 5′-AGGAAATCGTCCTTCAGCAG-3′, 5′-GATCGTACGAGGAGTAGGAG-3′, 5′-GTCTTGTAGAAGGGGCAGAA-3′, 5′-GATGATGTTCCTCAACATGC-3′, 5′-GACGGGCCATGTCGTAGAAG-3′, 5′-TTCTCAGACTGAGCCGTAGA-3′, 5′-GAATCACGTTCCAGGTGATC-3′, 5′-TACATAATGTTGCCCATTGC-3′, and 5′-GAACTTCATGGATGACAGCT-3′.

Cell dissociation, FACS, sample preparation, and RNA sequencing {#s17}
---------------------------------------------------------------

Type I NBs were sorted as described previously with minor modifications ([@bib7]; [@bib30]). Briefly, third-instar larva were washed in PBS, brains were dissected in Schneider's medium (21720024; Gibco) and collected in Rinaldini's solution at room temperature. Brains were dissociated in a dissociation solution (collagenase I \[C0130; Sigma-Aldrich\] and papain \[P4762; Sigma-Aldrich\]; final concentration 1 mg/ml in Rinaldini's solution) for 20 min at 25°C. Brains were washed twice in Rinaldini's solution and disrupted manually in supplemented Schneider's medium. NBs were sorted into supplemented Schneider's medium with a FACSAriaIII machine (BD) according to cell size and GFP intensity and incubated for respective times (1.5, 3, or 5 h) at 25°C. 20 min before the end of the incubation time, collagenase I and papain (Sigma-Aldrich) solutions were added (final concentration 1 mg/ml), and cells were pipetted up and down to dissociate NBs and newly formed GMCs. NBs and GMCs were sorted according to cell size and GFP intensity.

For cell staining, cells were sorted on coated glass-bottomed dishes and stained as described previously ([@bib7]). For RNA isolation, NBs and GMCs were sorted directly in TRIzol LS (10296010; Invitrogen).

Sample preparation and RNA sequencing (DigiTAG) {#s18}
-----------------------------------------------

Per experiment, total RNA from 1,000 to 3,000 FACS-sorted NBs and GMCs was isolated by TRIzol purification. We analyzed three independent biological replicates for each NB time point and two replicates for each GMC time point (Gene Expression Omnibus accession number GSE104049). Reverse transcription and enrichment for mRNAs was performed by incubating total RNA with 50 U Superscript III Reverse Transcriptase (18080044; Invitrogen), oligo(dT)20, 10 U RNaseOUT (Invitrogen), dNTPs, first strand buffer, MgCl~2~, and DTT for 50 min at 50°C and subsequently for 5 min at 85°C. To generate the second-strand cDNA, second-strand buffer (Invitrogen), dNTPs, RNase H, and DNA polymerase I (Invitrogen) were added to the first-strand cDNA and incubated for 2 h at 16°C. Double-stranded cDNA was purified using magnetic beads (AMPure XP beads; Beckman Coulter). Purified cDNA was simultaneously fragmented and tagged with adapter sequences by using the Nextera DNA Library Preparation Kit (Illumina) for 5 min at 55°C. After another purification step (AMPure XP beads; Beckman Coulter), tagmented cDNA was PCR amplified by Phusion HF master mix (Thermo Fisher Scientific), 20× Eva Green (Biotium), Nextera primers mix, Index 2 primers (N501-N506 for multiplexing), and modified Index 1 primers. The latter contains a random 8-mer molecular barcode that allowed us to extensively amplify our sequencing library without running into the risk of misrepresentations by PCR amplification artifacts. Purified libraries were subjected to 50-bp single-end sequencing on a Hiseq 2000 platform (Illumina).

Transcriptome data analysis {#s19}
---------------------------

### Alignment {#s20}

Unstranded reads were screened for ribosomal RNA by aligning with BWA (v0.7.12; [@bib47]) against known rRNA sequences (RefSeq). The rRNA subtracted reads were aligned with TopHat (v2.1.1; [@bib38]) against the *Drosophila* genome (FlyBase r6.12). Introns between 20 and 150,000 bp are allowed, which is based on FlyBase statistics. Microexon-search was enabled. Additionally, a gene model was provided as GTF (FlyBase r6.12).

### Deduplication {#s21}

Reads arising from duplication events are marked as such in the alignment (SAM/BAM files) as follows. The different tags are counted at each genomic position. Thereafter, the diversity of tags at each position is examined. First, tags are sorted descending by their count. If several tags have the same occurrence, they are further sorted alphanumerically. Reads sharing the same tag are sorted by the mean PHRED quality. Again, if several reads have the same quality, they are further sorted alphanumerically. Now the tags are cycled through by their counts. Within one tag, the read with the highest mean PHRED quality is the unique correct read and all subsequent reads with the same tag are marked as duplicates. Furthermore, all reads that have tags with one mismatch difference compared the pool of valid read tags are also marked as duplicates.

### Summarization {#s22}

Small nuclear RNA, rRNA, tRNA, small nucleolar RNA, and pseudogenes are masked from the GTF (FlyBase r6.12) with subtractBed from bedtools (v2.26.0; [@bib62]). The aligned reads were counted with HTSeq (v0.6.1; intersection-nonempty), and genes were subjected to differential expression analysis with DESeq2 (v1.12.4; [@bib50]).

Hierarchical clustering analysis {#s23}
--------------------------------

Genes are filtered by the indicated log2fc and an adjusted P value \< 0.05 in at least one pairwise comparison. In addition, a minimal expression of 5 RPM in at least one condition was required. The log2RPM (Fig. S2 a) or log2fc ([Fig. 2 c](#fig2){ref-type="fig"}) are hierarchically clustered ("euclidean" and "complete") and the tree cut into five (Fig. S2 a) or seven ([Fig. 2 c](#fig2){ref-type="fig"}) clusters (different cluster numbers were tested; [@bib41]). GO analysis was performed with FlyMine ([@bib52]).

FACS sorting of esg^+^ ISCs/EBs {#s24}
-------------------------------

FACS of esg^+^ cells was performed as previously described ([@bib21]). Briefly, after dissection of *Drosophila* midguts, the tissue was disrupted by elastase treatment (final concentration of 1 mg/ml for 1 h at 27°C). Guts were washed with PBS and pipetted up and down to dissociate the tissue. After centrifugation (20 min at 300*g* and 4°C), cell pellet was resuspended in PBS and sorted into TRIzol LS (Invitrogen) based on GFP intensity and cell size.

Quantitative RT-PCR analysis {#s25}
----------------------------

First-strand cDNA was generated using random primers on TRIzol-extracted total cell RNA. Quantitative PCR was done using IQ SYBR Green Supermix on a CFX96 cycler (Bio-Rad Laboratories). Expression of each gene was normalized to Act5c (NBs) or RpL32 (ISCs/EBs), and relative levels were calculated using the 2-^ΔΔCT^ method ([@bib49]). The following primer pairs were used: Act5c, 5′-AGTGGTGGAAGTTTGGAGTG-3′ and 5′-GATAATGATGATGGTGTGCAGG-3′; RpL32, 5′-CGCTTCAAGGGACAGTATCTG-3′ and 5′-AAACGCGGTTCTGCATGAG-3′; E(spl)mα, 5′-CTATGCCGAGATCGATGAGAAC-3′ and 5′-GAAGCGAACTGGGACATAGAC-3′; E(spl)mβ, 5′-GTGACCATAGCTTGATCCTCTAC-3′ and 5′-TTGGCCATCGTCTCAACTAC-3′; E(spl)mγ, 5′-CTGGACGAGCTAAAGGATCTTATG-3′ and 5′-GTTCCAGGATATCGGCTTTCTC-3′; E(spl)m7, 5′-CGTCAACACTCCACTCAGTATC-3′ and 5′-TCGTTGTCGCTGGCATATC-3′; E(spl)m8, 5′-TGGCTCAGGAAGAACAATCC-3′ and 5′-CAGGTGAGTCATCACCGATTT-3′; Vha68-2, 5′-TGTCCGAATACTTCCGTGATATG-3′ and 5′-CAGCGAGACGACCAGAAAT-3′; Vha100-2, 5′-GGACAGTCGTTGTGTTGTAGT-3′ and 5′-TCTGCTGATGGGTCTGTTTG-3′; VhaSFD, 5′-TGTGGCGTACTCATCAAAGG-3′ and 5′-CTTCGACGACGAGGACATTAC-3′; and VhaM9.7-b, 5′-TATCCGAGTGGGTGGCA-3′ and 5′-GTCCTCGGGCGAAGAAG-3′.

COMPLEAT complex enrichment analysis {#s26}
------------------------------------

The transcriptomics data were preprocessed using custom-made Python scripts. Log2fc gene expression data between indicated time points and cell types (e.g., NB vs. GMC) were calculated and enriched protein complexes were subsequently identified using the COMPLEAT algorithm ([@bib76]). Deregulated complexes were visualized using the Cytoscape platform ([@bib66]). Interaction data were obtained from the BioGRID interaction database ([@bib71]).

Brain tumor transplantation, Baf-A1 treatment and metastasis quantification {#s27}
---------------------------------------------------------------------------

L3 brains from UAS-*dcr2*/UAS-*brat*^RNAi^; *wor*-GAL4, *ase*-GAL80/+; UAS-stingerRFP were dissected and disrupted (see the Cell dissociation, FACS, sample preparation, and RNA sequencing section). Concentrations of RFP^+^ brat tumor cells were quantified on a Neubauer cell counter, and ∼1,000 cells were intrathoracically injected into 3--6-d-old adult females with a Nanoject II (Drummond). After a recovery phase of 4 h, flies were injected with either the v-ATPase inhibitor Baf-A1 (9.2 nL of 50 nM Baf-A1; EMD Millipore) or vehicle (DMSO in PBS). Brightfield, GFP, and RFP pictures of living flies were taken on a SteREO Lumar.V12 (Zeiss) with a Pursuit-XS monochrome camera (Diagnostic Instruments) every 24 h after transplantation. GFP autofluorescence signal was subtracted from tumor-specific RFP signal and displayed in false colors black-red-green-blue-cyan-magenta-yellow-white (BRGBCMYW) and subsequently merged with the corresponding brightfield image. The RFP-specific signal was quantified on the outlined area of whole flies after GFP autofluorescence subtraction on ImageJ. The mean intensity of all flies in one picture was plotted.

Statistics {#s28}
----------

Statistical analyses were performed with Prism 7 (GraphPad Software). Unpaired two-sided Student's *t* test was used to assess statistical significance between two genotypes/conditions. Mantel-Cox test was used to assess statistical significance in the survival of two conditions. No statistical methods were used to predetermine the sample size. Sample sizes for experiments were estimated based on previous experience with a similar setup that showed significance. Data distribution was assumed to be normal, but this was not formally tested. Experiments were not randomized, and the investigator was not blinded.

Online supplemental material {#s29}
----------------------------

Fig. S1 shows that sorted NBs divide asymmetrically and that both daughter cells express the expected cell markers (corresponds to [Fig. 1 a](#fig1){ref-type="fig"}, step 2). Fig. S2 shows that NB culture has modest effects on the NB transcriptome. Fig. S3 shows the transcriptional down-regulation of the v-ATPase in GMCs over time and that Vha68-2 mRNA is not asymmetrically localized during NB cell division. Fig. S4 shows that the v-ATPase is required for Notch-driven tumor progression. Video 1 shows a control type I NB that divides asymmetrically multiple times. After each division, the NB regrows to its original size before it continues dividing. (Video 1 corresponds to [Fig. 4 c](#fig4){ref-type="fig"}.) Videos 2 and 3 show *Vha100-2^RNAi^* NBs that divide asymmetrically multiple times. Regrowth potential upon cell division is impaired, resulting in decreasing NB volume. (Videos 2 and 3 correspond to [Fig. 4 c](#fig4){ref-type="fig"}.) Table S1 contains a complete list of genes differentially expressed in NBs and GMCs at 1.5, 3, and 5 h with a FDR of \<0.05. Table S2 contains a complete list of genes for all seven clusters of the hierarchical clustering analysis and all enriched GO terms for each gene cluster (corresponds to [Fig. 2 c](#fig2){ref-type="fig"}). Table S3 includes a complete list of enriched protein complexes (based on COMPLEAT analysis) for the following time points and cell types: 1.5 h GMC versus 1.5 h NB, 3 h GMC versus 3 h NB, 5 h GMC versus 5 h NB, and 5 h GMC versus 1.5 h GMC (corresponds to [Fig. 3, a--e](#fig3){ref-type="fig"}).
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